Series C · $400M
$400M Series C; $3.8B is the separate valuation.
Editorial intelligence brief
Editorial focus
Announced a Bristol Myers Squibb collaboration on August 20, 2026 to apply its molecular models and platform to antibody discovery; the announcement does not establish clinical outcomes.
Focus: Biomolecular structure prediction and therapeutic molecule design
Latest funding
$400M
Series C · source-backed
Tracked funding
$400M
Sum of itemized funding events
Latest valuation
Not tracked
No source-backed record
Latest revenue
Not tracked
Growth lifecycle position
Editorially verified updates
What changed
Announced a Bristol Myers Squibb collaboration on August 20, 2026 to apply its molecular models and platform to antibody discovery; the announcement does not establish clinical outcomes.
External coverage of Chai Discovery
Selected by relevance, date and publisher; grouped by story. External reporting is not independently verified by the map. Article dates are publisher timestamps supplied by the discovery feed; quieter profiles may show coverage up to 90 days old.
Last checked Oct 18, 2026.
No eligible recent coverage found. Verified updates and profile sources remain available above and below.
Source-backed financial history
Funding and financial history
Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.
Records
1
Sum of recorded funding
$400M
Coverage
partial
Partial history: earlier or intervening rounds may be missing. The sum covers only the announcements recorded here, not lifetime funding. Announced commitments may be paid over time; this is not a cash balance. Dates show announcements or first public reports, which can follow the investment itself.
One funding announcement recorded. More dated rounds are needed to show funding over time.
#1
Series C · $400M
Running tracked total: $400M
#1
Series C · $400M
Running tracked total: $400M
Sources and details for every recorded funding announcement, newest first.
Chai Discovery ↗ source for Series C $400M
Product surface
Products and model families
Recent models
Chai-1Chai-2Chai-3
Products
Chai Lab molecular-design platform
Open weights
Yes
API access
No
Review target
Weekly
Market position
Lifecycle and strategic signals
Research
Preview
Growth
Deployment
Growth: Public access & scaling
Focus
Biomolecular structure prediction and therapeutic molecule design
Signals
Scientific AIOpen weights
Taxonomy
Open Weight LabsBiotechAI for scienceResearch
Competitive context
Isomorphic LabsLatent LabsEvolutionaryScale
Infrastructure & distribution
Where Chai Discovery sits in the AI stack
01
Model layer
3 tracked model families
02
Access layer
Self-hostable weights
03
Market layer
Vertical + Enterprise
Public product surface
Chai Lab molecular-design platform
Stack signals
BiotechAI for scienceResearchScientific AIOpen weights
This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.
Evidence trail
Sources and corrections
Primary and public sources used to verify the structured company profile.
The Staticbreaker
Get the signal behind the week's AI changes.
The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.